CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

How Can Cardiometabolic Syndrome Reshapes Digital Tech Solution?

How Can Cardiometabolic Syndrome...

Superbugs: How You Can Defend Superbugs with the Help of Biotechnology Firms?

Superbugs: How You Can Defend...

Aria Pharmaceutical's Implemented AI for Generating New Innovative Insights

Aria Pharmaceutical's Implemented AI...

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Developing Patient-Centric Precision...

What the New EMA Draft

What the New EMA Draft "Guideline on...

Pharmaceutical Tablet Coating - Past, Present and Future

Pharmaceutical Tablet Coating - Past,...

Dynamic Commercial Aspects  of Life Sciences

Dynamic Commercial Aspects of Life...

How Can Cardiometabolic Syndrome Reshapes Digital Tech Solution?

How Can Cardiometabolic Syndrome...

Superbugs: How You Can Defend Superbugs with the Help of Biotechnology Firms?

Superbugs: How You Can Defend...

Aria Pharmaceutical's Implemented AI for Generating New Innovative Insights

Aria Pharmaceutical's Implemented AI...

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Developing Patient-Centric Precision...

What the New EMA Draft

What the New EMA Draft "Guideline on...

Pharmaceutical Tablet Coating - Past, Present and Future

Pharmaceutical Tablet Coating - Past,...

Dynamic Commercial Aspects  of Life Sciences

Dynamic Commercial Aspects of Life...

Most Common Antibiotic-Resistant Infections Caused by Bacteria

Life Sciences Review | Tuesday, March 01, 2022
Tweet

CRE is a bacterial family that is commonly found in our stomachs, but some of these bacteria can cause life-threatening blood infections and are antibiotic-resistant


Fremont, CA: Superbugs are viruses, parasites, bacteria, and fungi strains that are resistant to most antibiotics and other medications utilized to treat the infections they cause. Antibiotics have been used to treat bacteria that have adapted and changed in order to develop resistance. Superbugs are antibiotic-resistant bacteria that can cause severe bacterial infections that are extremely difficult to treat.


Common Antibiotic-Resistant Superbugs to Know About:


Multidrug-Resistant Acinetobacter: This bacteria's superbug strain, Acinetobacter baumannii, can be found in water, soil, and the skin. It develops antibiotic resistance faster than other bacteria and is most common in hospitals.


Neisseria gonorrhoeae: This strain of bacteria causes gonorrhea, an STD that was previously easily treated with antibiotics. Neisseria gonorrhoeae, on the other hand, is becoming increasingly resistant to them.


Carbapenem-Resistant Enterobacteriaceae (CRE): CRE is a bacterial family that is commonly found in our stomachs, but some of these bacteria can cause life-threatening blood infections and are antibiotic-resistant.


MRSA: MRSA (methicillin-resistant Staphylococcus aureus) Staphylococcus aureus is a difficult staph infection to treat. Although MRSA is antibiotic-resistant, it still responds to some antibiotics, and the frequency of life-threatening MRSA has decreased.


Clostridium difficile (C.diff): C. diff is a bacteria that lives in your intestines and can cause severe diarrhea if it grows too large. It can be passed from person to person via spores in bathrooms and on clothing, and it is not always treatable with antibiotics. C. diff can be fatal if not treated.


Weekly Brief

loading
Top 10 Canada Life Science Consulting Companies - 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/most-common-antibioticresistant-infections-caused-by-bacteria-nwid-734.html